Category: Uncategorized

THE SHIFT TO BIOLOGICAL DRUGS. View in LinkedIn

A PROMISING REGENERATIVE MEDICINE APPROACH TO UNTREATABLE EYE DISEASES USING RETINAL CELLS. A number of eye diseases have proved very challenging to treat and manage. This cell-based approach may have more success, since the difficulties of structural repair of big tissue areas in some of these diseases is proving beyond the ability of small molecules or monoclonals. http://m.yahoo.com/w/legobpengine/finance/news/retina-institute-japan-dainippon-sumitomo-080000985.html?.intl=us&.lang=en-us View in LinkedIn

SOCIAL MEDIA HAS BECOME ESSENTIAL FOR BIZ DEVELOPMENT. Early in my career, BD was about networking at frenetic conferences and scanning every obscure cranny of the printed news media. This tended to be inefficient and resulted in way too much follow-up travel. Now it is possible to effectively and efficiently network, gain access, and find out basic data in a product acquisition or out-licensing situation, by using social media. http://commercialbiotechnology.com/index.php/jcb/article/view/603 View in LinkedIn

ARE WE MEETING THE NEW WORKFORCE IN THE MIDDLE? An interesting contribution to the debate. http://lnkd.in/NHQKr8 View in LinkedIn

GENENTECH/ ROCHE's EXPENSIVE CANCER DRUG AVASTIN caused a firestorm for compounding pharmacies. Compounding pharmacies diluted Avastin for use for Macular Degeneration, to avoid the repurposed Roche Avastin-mimick Lucentis. Diluted Avastin cost 50 USD per shot vs 2,000 USD for Lucentis. Unfortunately, due to a small but serious group of eye infections, FDA understandably came down hard. We now risk throwing out the baby with the bathwater, to the likely delight of the innovator. View in LinkedIn

OVER 5,000 ONCOLOGY PROJECTS IN CLINICAL TRIALS. View in LinkedIn

AN INTERESTING VIEW OF THE INEVITABILITY OF PERSONALIZED MEDICINE, and how it may already be shaping medicine. While the author states that our ability to interpret the kinds of data coming from whole genome screening in increasing rapidly, this is not supported by general experience. At the present time, the tools are advancing faster than our development of thorough, expert interpretations of what the data mean at a medical level. http://social.eyeforpharma.com/column/personalized-medicine-new-technologies-improve-personalization-and-precision View in LinkedIn

OVER 5,000 ONCOLOGY PROJECTS IN CLINICAL TRIALS. View in LinkedIn

BEAUTIFUL INFOGRAPHIC ON DRUG PIPELINE BY INDICATION. http://lnkd.in/CQDwMU View in LinkedIn

IF 98% OF THE UNIVERSE IS INSCRUTABLE DARK MATTER, beyond this being a jaw-dropping factoid, how will our relation with matter change when we understand it? What properties will it have, and will humans harness it to do work? I am used to an awareness of feeble knowledge, but this is beyond crazy. View in LinkedIn